
iRhythm Technologies (IRTC) Stock Forecast & Price Target
iRhythm Technologies (IRTC) Analyst Ratings
Bulls say
iRhythm Holdings is positioned to be a leader in cardiac monitoring, with its innovative technology and partnerships driving steady revenue growth. The company's strong fundamentals, including a large addressable market and increasing penetration in the primary care physician channel, make it a compelling investment opportunity. In addition, the company's progress in remedying the FDA warning letter and its successful launch of a next-generation algorithm are positive indicators for future growth. However, potential risks such as increased competition and negative reimbursement developments should be monitored.
Bears say
iRhythm Holdings is expected to face operational hiccups and risks surrounding their DoJ inquiry and FDA warning letter, potentially leading to negative consequences. In addition, the delay in releasing their Gen 3 algorithm due to resource prioritization for cybersecurity may lead to missed growth opportunities in the long-term. The company's valuation at 6x projected 12-24 month revenue estimate also raises concerns about the company's potential for profitability and market saturation.
This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.
iRhythm Technologies (IRTC) Analyst Forecast & Price Prediction
Start investing in iRhythm Technologies (IRTC)
Order type
Buy in
Order amount
Est. shares
0 shares